By Matt Skoufalos
Melmark, Inc. of Berwyn, Pennsylvania promoted Tom Crofcheck to VP and CFO, succeeding the retiring Joseph Zakrzewski. Crofcheck most recently was Director of Finance for Melmark Pennsylvania. He’ll take over the role in late September.
Paramit Corporation of Morgan Hill, California named Bruce Richardson as President of its Product Development Group. Richardson has 30 years of extensive experience in the medical and biotech industries. Named on 37 patents, he held a variety of executive and senior management positions. In 2007, Richardson founded Accel Biotech LLC., and the firm was acquired by Ximedica in 2016.
Millar, Inc. of Houston, Texas named Alfred Coats as its chairman of the board. Coats was a professor at Baylor for 28 years, founded LifeTech, Inc., where he was President and CEO until selling the company in 2013. Coats was also director of the Space Life Sciences Division of the Universities Space Research Association for a decade. Currently, he is the managing partner of AlphaQuest Consulting, and an investor member of the Houston Angel Network where he is chairman of the Life Sciences Group.
Signant Health of Philadelphia, Pennsylvania, formerly CRF Health and Bracket, named Anthony Todd Everhart clinical VP of Internal Medicine. Everhart is Board-certified in Internal Medicine and a Fellow of the American College of Physicians. He was previously VP of Medical Affairs and VP of Medical Informatics at Chiltern and Covance.
The New York, New York-based SWORD Health appointed a Clinical Advisory Board of specialists comprising:
- Jose Rodriguez, MD (Chairman of the Board): Orthopaedic Surgeon, Hospital for Special Surgery; Editorial Board of Journal of Arthroplasty, Bone and Joint Journal, Clinical Orthopaedics and Related Research;
- Jorge Lains, MD: Physical and Rehabilitation Medicine (PRM) Specialist; President of the International Society of Physical & Rehabilitation Medicine (2016-2018);
- Gerard Francisco, MD, PhD: PRM Specialist; Board of Directors of the American Board of Physical Rehabilitation and Medicine; Chairman and Professor, McGovern Medical School, PRM Department;
- Chris Furmansky, PhD: Phd in Cognitive Psychology; Director of Innovation, Stanford Health Care (2013-2016)
Innovatus Imaging of Pittsburgh, Pennsylvania named Dave Johnson its CEO, replacing founder Dennis Wulf, who will now serve as Chairman of the Board.
Johnson most recently served as CEO of Joerns Healthcare; he was a team leader in the development of Stryker’s acute care and ICU beds, ER and EMS Stretchers; ConMed’s GI/Endosurgery products and Invacare’s Power Rehab, Continuing Care and Personal Care line.
The Doctors Company of Napa, California named David L. Feldman its Chief Medical Officer, succeeding David Troxel, who retired after more than 13 years in the role. Feldman will continue to serve as SVP and CMO at Healthcare Risk Advisors (HRA), formerly Hospitals Insurance Company and FOJP Service Corporation, which was recently acquired by The Doctors Company Group. Prior to HRA, Feldman was VP for patient safety, VP of perioperative services, and vice chairman of the department of surgery at Maimonides Medical Center in Brooklyn, New York. Feldman also serves on the steering committee of the American College of Surgeons (ACS) for retraining and retooling of practicing surgeons.
Shield Diagnostics of San Jose, California appointed David Esposito to its Board of Directors. Esposito is CEO of ONL Therapeutics, the former CEO of Armune BioScience, and has been President of Phadia US Inc.
Pneuma Respiratory, Inc. of Boone, North Carolina elevated board member Jay Morgan to chairman of the board. Prior chair Walt Robb will remain a member of the board. Morgan was VP of Global Innovation and Design for Bayer Consumer Care, has been VP of Global Innovation for Merck Consumer Health and COO of Research Operations for Merck Consumer Health. He is a founding partner of Pedal, and studied chemistry at Ohio Northern University.
Varian of Palo Alto, California named Phil Febbo, chief medical officer at Illumina, to its board of directors. Febbo has held his current position with Illumina since 2018. He previously served as CMO of Genomic Health, was a professor of medicine and urology at the University of California, San Francisco (UCSF), and currently serves on the board of the American College of Medical Genetics and Genomics Foundation.
AGS Health (AGS) of Newark, New Jersey named Patrice Wolfe its CEO. Wolfe has been CEO at Medicity and HDMS, and succeeds founder and CEO Devendra Saharia, who will be leaving the company.
Erasca of San Diego, California promoted Gary Yeung to COO and CFO, named David Chacko chief business officer, Les Brail VP of clinical development, and Karen Gilmore VP of finance. The company also recruited a research and development (R&D) advisory board comprising:
- Bruce Roth, Ph.D., as senior chemistry advisor
- Dave Matthews, Ph.D., as senior crystallography advisor
- Greg Cosma, Ph.D., as senior development advisor
- Paul Pearson, Ph.D., as senior ADME/PK advisor
- Jane Chang, Ph.D., as senior toxicology advisor
- James Freddo, M.D., as senior medical advisor
- Linda Robertson, Ph.D., as senior regulatory affairs advisor
Common Sensing of Cambridge, Massachusetts named John R. Dwyer, President of the Global Alzheimer’s Platform Foundation and Co-Founder of Telcare, Inc., to its Board of Directors. Dwyer began his career as an attorney for the Washington DC based law firm of Arent, Fox LLP.
MCRA of Washington, D.C. named Tonya N. Dowd its VP of Reimbursement, Health Economics, and Market Access. Dowd most recently was Global Franchise Director, Healthcare Economics and Market Access at Johnson & Johnson Medical Devices. She has 25 years of reimbursement and market access experience and holds an MPH from the University of California Los Angeles.
Aloe Care Health of New York, New York has added Bern Terry as SVP of strategic partnerships. He was previously the business development lead for Philips Lifeline. Terry has also served as Head of Healthcare Partnerships at CareLinx.
Children’s Minnesota of Minneapolis, Minnesota named Brenda McCormick CFO and SVP of finance and Jennifer Soderholm chief development officer and president of the Children’s Minnesota Foundation. McCormick joins Children’s from Smiths Medical, where she was CFO and SVP of finance; she has also been VP, corporate controller and principal accounting officer at Valspar. Soderholm joins Children’s from Planned Parenthood North Central States where she was EVP and chief development officer. She also previously served as president of Children’s HeartLink.
Cricket Health of San Francisco, California appointed Colleen Reitan to the company’s board of directors and Adam Hameed as chief development officer. Reitan is a former health plan executive with Blue Cross and Blue Shield of Minnesota (BCBS of MN), and Health Care Service Corporation (HCSC). Most recently, she served was EVP with HCSC and has been president and COO of BCBS of MN. Reitan is an independent director for Alnylam Pharmaceuticals and previously served as chief revenue officer with PlanSource, Alegeus Technologies, and Silverlink Communications. He was also SVP of the go-to-market team within Optum.
Chartspan of Greenville, South Carolina named Sarath Degala SVP of BIP Capital, to its Board of Directors. Degala is the former Chief Strategy Officer at Tenet Health, CEO of Baylor, Scott and White Health, and VP of Revenue Cycle at WellStar and Ascension Health. He currently serves on the Board of Directors of PriorAuthNow, Nview Health, and OncoLens and the advisory boards of ThinkResearch, Cipher Health, and Streamline Health.
Genetesis Inc. of Mason, Ohio named Peter Donato as its Chief Business Officer. He most recently was CFO at Neuronetics and has been the CFO at Assurex Health. D
Confirm BioSciences of San Diego, California named Albert Berger as its new CEO, succeeding founder Zeynep Ilgaz, who will chair the board of directors and become its chief advisor. Former chief commercial officer Nikhil Nayak will ascend to COO.
Berger previously was VP and GM of Redwood Toxicology Laboratory, a division of Alere Toxicology until its acquisition by Abbott Laboratories in October 2017.